AbbVie (NYSE:ABBV) is a global,
research-based biopharmaceutical company formed in 2013 following
separation from Abbott.
AbbVie combines the focus and passion of a
leading-edge biotech with the expertise
and capabilities of a long-established pharmaceutical leader to develop
and market advanced therapies that address some of the world’s most
complex and serious diseases.
In 2013, AbbVie will employ approximately
21,000 people worldwide and markets medicines
in more than 170 countries.